VNDA (STOCKS)
Vanda Pharmaceuticals Inc.
$5.030000
-0.160000 (-3.08%)
Prev close: $5.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mihael Hristos Polymeropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $304.13M
- Employees
- 368
- P/E (TTM)
- -1.09
- P/B (TTM)
- 1.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.04 | $-0.60 | -0.4407 | -73.54% |
|
Mar 2026 (Q1)
|
$-0.82 | $-0.70 | -0.1182 | -16.84% |
|
Dec 2025 (Q4)
|
$-0.46 | $-1.35 | +0.8915 | +65.96% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.46 | +0.0824 | +17.82% |
Financial Statements
| Revenues | $215.72M |
| Benefits Costs and Expenses | $392.92M |
| Costs And Expenses | $401.39M |
| Operating Expenses | $401.39M |
| Selling, General, and Administrative Expenses | $263.45M |
| Research and Development | $116.96M |
| Other Operating Expenses | $20.98M |
| Operating Income/Loss | -$185.67M |
| Income/Loss From Continuing Operations After Tax | -$274.85M |
| Income/Loss From Continuing Operations Before Tax | -$177.20M |
| Income Tax Expense/Benefit | $97.65M |
| Income Tax Expense/Benefit, Deferred | $97.21M |
| Net Income/Loss | -$274.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$274.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$274.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.63 |
| Diluted Earnings Per Share | -$4.63 |
| Basic Average Shares | 118,993,758 |
| Diluted Average Shares | 118,993,758 |
| Assets | $412.47M |
| Current Assets | $264.48M |
| Inventory | $1.68M |
| Other Current Assets | $262.81M |
| Noncurrent Assets | $147.98M |
| Fixed Assets | $2.58M |
| Other Non-current Assets | $145.41M |
| Liabilities | $192.28M |
| Current Liabilities | $164.03M |
| Wages | $8.12M |
| Other Current Liabilities | $155.91M |
| Noncurrent Liabilities | $28.26M |
| Equity | $220.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $220.19M |
| Liabilities And Equity | $412.47M |
| Net Cash Flow From Operating Activities | -$142.33M |
| Net Cash Flow From Operating Activities, Continuing | -$142.33M |
| Net Cash Flow From Investing Activities | $120.27M |
| Net Cash Flow From Investing Activities, Continuing | $120.27M |
| Net Cash Flow From Financing Activities | -$2.79M |
| Net Cash Flow From Financing Activities, Continuing | -$2.79M |
| Exchange Gains/Losses | -$253.00K |
| Net Cash Flow | -$25.10M |
| Net Cash Flow, Continuing | -$24.85M |
| Comprehensive Income/Loss | -$275.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$275.21M |
| Other Comprehensive Income/Loss | -$54.74M |
| Other Comprehensive Income/Loss Attributable To Parent | -$358.00K |